Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS)

PHASE2TerminatedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

October 24, 2018

Primary Completion Date

August 3, 2022

Study Completion Date

December 20, 2022

Conditions
Amyotrophic Lateral Sclerosis (ALS)
Interventions
DRUG

L-Serine

L-Serine is a naturally occurring dietary amino acid. It is abundant in soy products, some edible seaweeds, sweet potatoes, eggs and meat.

Trial Locations (1)

03756

Dartmouth-Hitchcock Medical Center, Lebanon

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Brain Chemistry Labs

OTHER

lead

Elijah W. Stommel

OTHER